Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance
Gespeichert in:
| Veröffentlicht in: | Diabetes care 2015-01, Vol.38 (1), p.e7-e8 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e8 |
|---|---|
| container_issue | 1 |
| container_start_page | e7 |
| container_title | Diabetes care |
| container_volume | 38 |
| creator | Rudovich, Natalia Pivovarova, Olga Gögebakan, Özlem Sparwasser, Andrea Doehner, Wolfram Anker, Stefan D Arafat, Ayman M Bergmann, Andreas Nauck, Michael A Pfeiffer, Andreas F H |
| description | |
| doi_str_mv | 10.2337/dc14-1452 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1640482085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1640482085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-fafa44cb4e017be960978a04e396ddd92a1c24829274c0f12eb642c7d71e6b043</originalsourceid><addsrcrecordid>eNo9kblOxDAQhi0EguUoeAHkEoqArxwuEYIFaSUooI4ce7IYZe3FdjjeiMfEYYFqRqNv_jl-hI4pOWec1xdGU1FQUbItNKOSl0VZimYbzQgVsiilZHtoP8YXQogQTbOL9lhZ8oYzPkNf130POmHfY_jwS3B-jNi6FNTbJldmZZ2NuZCsd3EC54uHgmLlzIUPeH73gL3D2gY9DplxS7wOvlApWDVgN8UxQLIar2GdrIGsjuPYveSpEb_b9IyNzTsEcAnHpJbwM2M5jNpHwMkPEJTTcIh2ejVEOPqNB-jp5vrx6rZY3M_vri4XheaMpKJXvRJCdwIIrTuQFZF1o4gALitjjGSKaiYaJlktNOkpg64STNemplB1RPADdLrRzVe8jhBTu7JRwzAoB_kfLa0Eyf2kKTN6tkF18DEG6Nt1sCsVPltK2smYdjKmnYzJ7Mmv7NitwPyTf07wbwPKi-4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1640482085</pqid></control><display><type>article</type><title>Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Rudovich, Natalia ; Pivovarova, Olga ; Gögebakan, Özlem ; Sparwasser, Andrea ; Doehner, Wolfram ; Anker, Stefan D ; Arafat, Ayman M ; Bergmann, Andreas ; Nauck, Michael A ; Pfeiffer, Andreas F H</creator><creatorcontrib>Rudovich, Natalia ; Pivovarova, Olga ; Gögebakan, Özlem ; Sparwasser, Andrea ; Doehner, Wolfram ; Anker, Stefan D ; Arafat, Ayman M ; Bergmann, Andreas ; Nauck, Michael A ; Pfeiffer, Andreas F H</creatorcontrib><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc14-1452</identifier><identifier>PMID: 25538323</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Intravenous ; Aged ; Atrial Natriuretic Factor - blood ; Diabetes Mellitus, Type 2 - blood ; Female ; Gastric Inhibitory Polypeptide - administration & dosage ; Glucagon-Like Peptide 1 - administration & dosage ; Glucose Intolerance - drug therapy ; Humans ; Male ; Middle Aged ; Overweight - blood</subject><ispartof>Diabetes care, 2015-01, Vol.38 (1), p.e7-e8</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c320t-fafa44cb4e017be960978a04e396ddd92a1c24829274c0f12eb642c7d71e6b043</citedby><cites>FETCH-LOGICAL-c320t-fafa44cb4e017be960978a04e396ddd92a1c24829274c0f12eb642c7d71e6b043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25538323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rudovich, Natalia</creatorcontrib><creatorcontrib>Pivovarova, Olga</creatorcontrib><creatorcontrib>Gögebakan, Özlem</creatorcontrib><creatorcontrib>Sparwasser, Andrea</creatorcontrib><creatorcontrib>Doehner, Wolfram</creatorcontrib><creatorcontrib>Anker, Stefan D</creatorcontrib><creatorcontrib>Arafat, Ayman M</creatorcontrib><creatorcontrib>Bergmann, Andreas</creatorcontrib><creatorcontrib>Nauck, Michael A</creatorcontrib><creatorcontrib>Pfeiffer, Andreas F H</creatorcontrib><title>Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><subject>Administration, Intravenous</subject><subject>Aged</subject><subject>Atrial Natriuretic Factor - blood</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Female</subject><subject>Gastric Inhibitory Polypeptide - administration & dosage</subject><subject>Glucagon-Like Peptide 1 - administration & dosage</subject><subject>Glucose Intolerance - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Overweight - blood</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kblOxDAQhi0EguUoeAHkEoqArxwuEYIFaSUooI4ce7IYZe3FdjjeiMfEYYFqRqNv_jl-hI4pOWec1xdGU1FQUbItNKOSl0VZimYbzQgVsiilZHtoP8YXQogQTbOL9lhZ8oYzPkNf130POmHfY_jwS3B-jNi6FNTbJldmZZ2NuZCsd3EC54uHgmLlzIUPeH73gL3D2gY9DplxS7wOvlApWDVgN8UxQLIar2GdrIGsjuPYveSpEb_b9IyNzTsEcAnHpJbwM2M5jNpHwMkPEJTTcIh2ejVEOPqNB-jp5vrx6rZY3M_vri4XheaMpKJXvRJCdwIIrTuQFZF1o4gALitjjGSKaiYaJlktNOkpg64STNemplB1RPADdLrRzVe8jhBTu7JRwzAoB_kfLa0Eyf2kKTN6tkF18DEG6Nt1sCsVPltK2smYdjKmnYzJ7Mmv7NitwPyTf07wbwPKi-4</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Rudovich, Natalia</creator><creator>Pivovarova, Olga</creator><creator>Gögebakan, Özlem</creator><creator>Sparwasser, Andrea</creator><creator>Doehner, Wolfram</creator><creator>Anker, Stefan D</creator><creator>Arafat, Ayman M</creator><creator>Bergmann, Andreas</creator><creator>Nauck, Michael A</creator><creator>Pfeiffer, Andreas F H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201501</creationdate><title>Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance</title><author>Rudovich, Natalia ; Pivovarova, Olga ; Gögebakan, Özlem ; Sparwasser, Andrea ; Doehner, Wolfram ; Anker, Stefan D ; Arafat, Ayman M ; Bergmann, Andreas ; Nauck, Michael A ; Pfeiffer, Andreas F H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-fafa44cb4e017be960978a04e396ddd92a1c24829274c0f12eb642c7d71e6b043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Administration, Intravenous</topic><topic>Aged</topic><topic>Atrial Natriuretic Factor - blood</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Female</topic><topic>Gastric Inhibitory Polypeptide - administration & dosage</topic><topic>Glucagon-Like Peptide 1 - administration & dosage</topic><topic>Glucose Intolerance - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Overweight - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rudovich, Natalia</creatorcontrib><creatorcontrib>Pivovarova, Olga</creatorcontrib><creatorcontrib>Gögebakan, Özlem</creatorcontrib><creatorcontrib>Sparwasser, Andrea</creatorcontrib><creatorcontrib>Doehner, Wolfram</creatorcontrib><creatorcontrib>Anker, Stefan D</creatorcontrib><creatorcontrib>Arafat, Ayman M</creatorcontrib><creatorcontrib>Bergmann, Andreas</creatorcontrib><creatorcontrib>Nauck, Michael A</creatorcontrib><creatorcontrib>Pfeiffer, Andreas F H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rudovich, Natalia</au><au>Pivovarova, Olga</au><au>Gögebakan, Özlem</au><au>Sparwasser, Andrea</au><au>Doehner, Wolfram</au><au>Anker, Stefan D</au><au>Arafat, Ayman M</au><au>Bergmann, Andreas</au><au>Nauck, Michael A</au><au>Pfeiffer, Andreas F H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2015-01</date><risdate>2015</risdate><volume>38</volume><issue>1</issue><spage>e7</spage><epage>e8</epage><pages>e7-e8</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><cop>United States</cop><pmid>25538323</pmid><doi>10.2337/dc14-1452</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-5992 |
| ispartof | Diabetes care, 2015-01, Vol.38 (1), p.e7-e8 |
| issn | 0149-5992 1935-5548 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1640482085 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Administration, Intravenous Aged Atrial Natriuretic Factor - blood Diabetes Mellitus, Type 2 - blood Female Gastric Inhibitory Polypeptide - administration & dosage Glucagon-Like Peptide 1 - administration & dosage Glucose Intolerance - drug therapy Humans Male Middle Aged Overweight - blood |
| title | Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A51%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20exogenous%20intravenous%20administrations%20of%20GLP-1%20and/or%20GIP%20on%20circulating%20pro-atrial%20natriuretic%20peptide%20in%20subjects%20with%20different%20stages%20of%20glucose%20tolerance&rft.jtitle=Diabetes%20care&rft.au=Rudovich,%20Natalia&rft.date=2015-01&rft.volume=38&rft.issue=1&rft.spage=e7&rft.epage=e8&rft.pages=e7-e8&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dc14-1452&rft_dat=%3Cproquest_cross%3E1640482085%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1640482085&rft_id=info:pmid/25538323&rfr_iscdi=true |